Seoul, South Korea * June 11-14, 2026 Poster A-0294 Retrograde Ureteral Dosing in Nonhuman Primates for Drug Delivery to the Kidney

Suwon, South Korea * May 29, 2026 " A New Nonhuman Primate Preclinical Model of Dry Age-Related Macular Degeneration " Session 3-1, 2:30-3:00 PM

San Diego, CA June 22-25, 2026

We hereby announce that our subsidiaries, CMIC Pharma Science Co., Ltd. (Head Office: Hokuto City, Yamanashi Prefecture; President & CEO: Takahiro Natsume; hereinafter “CMIC Pharma Science”) and Hamamatsu Pharma Research, Inc. (Head Office: Hamamatsu City, Shizuoka Prefecture; President: Takahiro Natsume; hereinafter “Hamamatsu Pharma Research”) will be integrated through an absorption-type merger, with CMIC Pharma Science as the surviving company and Hamamatsu Pharma Researc

Hamamatsu Pharma Research is pleased to announce that our company, in collaboration with Hakuto Co., Ltd. and Samurai Imaging Partners Co., Ltd., has launched the “Radiopharmaceutical Drug Discovery Support Project.” By leveraging the expertise and technologies of each company, we will support preclinical and early clinical research in Japan, while providing greater added value to our customers. Furthermore, we will strengthen collaboration with domestic and international CRO

San Diego, USA * Mar. 22 - 25 " Retrograde Ureteral Catheterization for Renal Pelvis Access. A Feasibility Study in Cynomolgus Macaques. " Abstract No. 3024 / 23 March 2026 / 9:15 AM Poster No. A125, at Tox Expo, Hall B

Lisbon, Portugal * Mar. 23 - 25

Pharmacology Research & Perspectives , vol. 13, 1. https://doi.org/10.1002/prp2.70052 "Intravitreal Administration of Avacincaptad Pegol...

Evaluation of brain activation related to resting pain using functional magnetic resonance imaging in cynomolgus macaques undergoing knee...

Regenerative effects of platelet-rich plasma releasate injection in rabbit discs degenerated by intradiscal injection of condoliase |...

We hereby announce that Hamamatsu Pharma Research, Inc. has joined as a subsidiary company of CMIC HOLDINGS Co., Ltd. Notice Concerning...

Potential sex differences in activation of pain-related brain regions in nonhuman primates with a unilateral spinal nerve ligation Murata...

UPDATED: Dr. Liston featured in Stroke's Spotlight. Dr. Ted Liston et al.'s 2022 Stroke publication garnered 3rd place, American Heart...

*UPDATED*: Cover art for November 2022 issue (Vol. 4, Issue 11). Announcing publication of "Regional brain activation during rectal...

HPR announces publication of a brain imaging study in a NHP model of unilateral neuropathy.

Neuroprotective effect of brimonidine in a NHP model of ocular hypertension.

Announcing Astrocyte Pharmaceuticals' efficacy study of AST-004 in a NHP model of stroke! For more details, click here

HPR's first paper about a macaque model of ulcerative colitis in 2020 is now open to everyone! Click and check the paper